BridgeBio Pharma Inc
BBIO
$65.80-0.26%
End of day · as of Oct 1, 2026, 1:00 AM ET
Mkt cap
$13.24B
EV/Sales
29.2
P/E ratio
N/A
FY2025 Revenue
$502.08M
EPS (TTM)
$-3.56
Gross Margin (FY2025)
95.82%
Profit Margin (FY2025)
-145.98%
Beta
0.97
Div yield
N/A
Sector
Healthcare
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported BBIO revenue for 2025-12-31 was $502.1M. Net income was -$732.9M. Revenue was up 126.3% from 2024-12-31 to 2025-12-31. BBIO currently screens at market cap $13.24B.
Use this BBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BBIO income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
BridgeBio Pharma Inc (BBIO) is a biotechnology company in the Healthcare sector.
Latest cached BridgeBio Pharma Inc (BBIO) revenue for Dec 31, 2025 was $502.1M. Net income was -$732.9M. Statements: https://lician.com/financials/bbio
BridgeBio Pharma Inc (BBIO) market capitalization is $13.24B on the latest cached snapshot.
BridgeBio Pharma Inc (BBIO) cached previous close $65.97; day range $65.61 – $67.32; volume 2,765,208. Session quote: https://lician.com/quote/bbio
BridgeBio Pharma Inc (BBIO) latest cached earnings event is "BBIO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BBIO filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/bbio